We are live on ! Find out more
RAPT

RAPT Therapeutics
RAPT

Delisted

RAPT was delisted on the 2nd of March, 2026.

Back to rankings

98 hedge funds and large institutions have $691M invested in RAPT Therapeutics in 2022 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 38 increasing their positions, 20 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 8

90% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 20

31% more capital invested

Capital invested by funds: $527M → $691M (+$164M)

17% more funds holding

Funds holding: 84 → 98 (+14)

0.1% more ownership

Funds ownership: 12.53% → 12.63% (+0.1%)

0% more funds holding in top 10

Funds holding in top 10: 9 → 9 (0)

Holders
98
Holders Change
+14
Holders Change %
+16.67%
% of All Funds
1.69%
Holding in Top 10
9
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.16%
New
22
Increased
38
Reduced
20
Closed
8
Calls
$19.9M
Puts
–
Net Calls
+$19.9M
Net Calls Change
+$13M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$18.5M
2
O
OrbiMed
New York
+$9.1M
3
WP
Woodline Partners
California
+$8.26M
4
GPP
Great Point Partners
Connecticut
+$7.45M
5
N
Nuveen
North Carolina
+$4.37M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$29.7M
2
KXA
KPCB XV Associates
California
-$15.3M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$12.3M
4
KCM
Kingdon Capital Management
New York
-$8.22M
5
ROTUOC
Regents of the University of California
California
-$7.69M
Name Holding Trade Value Shares
Change 		Change in
Stake
Invesco
26
Invesco
Georgia
$3.73M +$3.66M +19,367 New
PIM
27
Ponoi II Management
California
$3.5M – – –
Two Sigma Advisers
28
Two Sigma Advisers
New York
$3.29M -$1.08M -5,700 -25%
Citadel Advisors
29
Citadel Advisors
Florida
$3.18M +$2.81M +14,863 +888%
ROTUOC
30
Regents of the University of California
California
$2.85M -$7.69M -40,644 -73%
Wellington Management Group
31
Wellington Management Group
Massachusetts
$2.71M -$127K -671 -5%
SSA
32
Schonfeld Strategic Advisors
New York
$2.56M -$912K -4,819 -27%
Millennium Management
33
Millennium Management
New York
$2.51M -$1.81M -9,545 -42%
AIIC
34
AJU IB Investment Company
South Korea
$2.39M – – –
D.E. Shaw & Co
35
D.E. Shaw & Co
New York
$2.39M +$2.35M +12,435 New
TD Asset Management
36
TD Asset Management
Ontario, Canada
$2.3M – – –
ECM
37
ExodusPoint Capital Management
New York
$2.26M +$973K +5,144 +78%
GTC
38
Ghost Tree Capital
New York
$2.17M -$1.77M -9,375 -45%
BOTOTLSJU
39
Board of Trustees of The Leland Stanford Junior University
California
$1.98M +$1.92M +10,155 New
Bank of New York Mellon
40
Bank of New York Mellon
New York
$1.94M +$205K +1,086 +12%
Rafferty Asset Management
41
Rafferty Asset Management
New York
$1.71M +$1.68M +8,901 New
UOC
42
UBS O'Connor
Illinois
$1.68M -$211K -1,117 -11%
Citigroup
43
Citigroup
New York
$1.58M +$730K +3,860 +89%
Manulife (Manufacturers Life Insurance)
44
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.47M -$7K -37 -0.5%
Swiss National Bank
45
Swiss National Bank
Switzerland
$1.35M +$14.2K +75 +1%
Bank of America
46
Bank of America
North Carolina
$1.19M +$954K +5,044 +449%
JRP
47
Jasper Ridge Partners
California
$1.1M – – –
Barclays
48
Barclays
United Kingdom
$1.08M +$1M +5,299 +1,611%
GCP
49
GSA Capital Partners
United Kingdom
$912K +$633K +3,346 +241%
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$835K +$62.6K +331 +8%
1
2
3 4 5

RAPT Hedge Fund Activity: Q3 2022 in Review

98 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in RAPT Therapeutics (RAPT) for Q3 2022, worth a combined $691M — up 31% from $527M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new RAPT positions and 8 closed out — a net gain of 14 holders — while 38 added to existing stakes and 20 trimmed.

The largest buyer was State Street, adding an estimated $18.5M. The largest seller was T. Rowe Price Associates, cutting an estimated $29.7M.

  • 98 institutional investors held RAPT Therapeutics (RAPT) as of Q3 2022, up from 84 in Q2 2022.
  • Funds reported $691M of RAPT Therapeutics stock for Q3 2022, up 31% quarter-over-quarter.
  • 22 funds opened new RAPT Therapeutics positions in Q3 2022 and 8 closed out, a net change of +14 holders.
  • The largest RAPT Therapeutics buyer in Q3 2022 was State Street, an estimated $18.5M added.
  • The largest RAPT Therapeutics seller in Q3 2022 was T. Rowe Price Associates, an estimated $29.7M sold.

Based on aggregated 13F filings for Q3 2022.